Class Notes (891,495)
CA (533,257)
Brock U (12,386)
HLSC (928)
HLSC 4P99 (8)
Lecture 8

CHSC 4P99 Lecture 8: Therapeutic Trials II.pdf

3 Pages
58 Views

Department
Health Sciences
Course Code
HLSC 4P99
Professor
Brent Faught

This preview shows page 1. Sign up to view the full 3 pages of the document.

Loved by over 2.2 million students

Over 90% improved by at least one letter grade.

Leah — University of Toronto

OneClass has been such a huge help in my studies at UofT especially since I am a transfer student. OneClass is the study buddy I never had before and definitely gives me the extra push to get from a B to an A!

Leah — University of Toronto
Saarim — University of Michigan

Balancing social life With academics can be difficult, that is why I'm so glad that OneClass is out there where I can find the top notes for all of my classes. Now I can be the all-star student I want to be.

Saarim — University of Michigan
Jenna — University of Wisconsin

As a college student living on a college budget, I love how easy it is to earn gift cards just by submitting my notes.

Jenna — University of Wisconsin
Anne — University of California

OneClass has allowed me to catch up with my most difficult course! #lifesaver

Anne — University of California
Description
Therapeutic Trials II March-10-15 2:00 PM Therapeutic Literature 1. Was the assignment of patient to treatments really randomized? ○ Known probability of receiving one or the other treatments ○ Terms such as randomized trial or Radom allocation should appear in abstract, the methods, or even the title ○ Beware articles that state "patient were assigned at random"  Systematic bias □ Prognosis stratification ○ Non-randomized studies are vulnerable to showing larger false-positive treatment effects  Subject to systematic bias 2. Were all clinically relevant outcomes reported ○ Consider all outcomes:  Quality of life(QOL)  Total mortality (PYLL-potential years of life lost) (75-the age you die)  Return to work ○ Necessity for explicit, objective criteria for the clinical outcomes at interest ○ Double blind study  Influence if the physician knows the group you're in 3. Were the study patients recognizably similar to your own? ○ The clinical and demographic status must be described in detail for you to judge if subjects are similarto your patients ○ The value of knowing your age/type of your subjects is important 4. Did the authors consider both clinical and statistical significance Clinical significance Statistical significance Examines magnitude of difference (effect Determines whether the effect sizeis likely to be size) between treated and control patient truthful Determines if a patient is better or worse for Considered with avoiding type I (false-positive, having taken the treatment alpha error, 5%) and type II error (false-negative, beta error, 20%) error •Type I error cost time •Type II error doesn't cost time (because you
More Less
Unlock Document
Subscribers Only

Only page 1 are available for preview. Some parts have been intentionally blurred.

Unlock Document
Subscribers Only
You're Reading a Preview

Unlock to view full version

Unlock Document
Subscribers Only

Log In


OR

Don't have an account?

Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


OR

By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.


Submit